Drug · DIN 02448610
BYDUREON
4 SINGLE-DOSE DUAL CHAMBER PENS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 1, 2022; first marketed February 16, 2016.
- Drug Identification Number (DIN)
- 02448610
- Company (DIN owner)
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Suspension (Sustained-Release; Kit
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Exenatide A10BJ01
- Class
- Human
- Record last updated
- August 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EXENATIDE | 2 MG | DOSE |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 30, 2015: NOC 17427New Drug Submission (NDS)